Susquehanna International Group
TRIB

Susquehanna International Group’s Trinity Biotech TRIB Stock Holding History

Susquehanna International Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,249
Closed -$10.5K – 14123
2025
Q4 		$11.3K Buy
+14,249
New +$14K ﹤0.01% 12044
2025
Q1 		– Sell
-12,483
Closed -$11K – 13474
2024
Q4 		$11K Buy
+12,483
New +$16.7K ﹤0.01% 11978
2024
Q2 		– Sell
-13,572
Closed -$27.8K – 13255
2024
Q1 		$27.8K Buy
+13,572
New +$31.8K ﹤0.01% 11738
2023
Q2 		– Sell
-2,937
Closed -$13.8K – 13154
2023
Q1 		$13.8K Buy
+2,937
New +$15.1K ﹤0.01% 12142
2022
Q4 		– Sell
-2,320
Closed -$13K – 13689
2022
Q3 		$13K Buy
2,320
+200
+9% +$1.29K ﹤0.01% 12733
2022
Q2 		$13K Sell
2,120
-1,016
-32% -$6.2K ﹤0.01% 12462
2022
Q1 		$17K Sell
3,136
-1,424
-31% -$8.2K ﹤0.01% 12670
2021
Q4 		$33K Buy
+4,560
New +$43.1K ﹤0.01% 12720
2020
Q4 		– Sell
-2,837
Closed -$46.9K – 11750
2020
Q3 		$29K Sell
2,837
-673
-19% -$7.79K ﹤0.01% 10337
2020
Q2 		$38K Buy
3,510
+954
+37% +$7.27K ﹤0.01% 9820
2020
Q1 		$14K Buy
+2,556
New +$13.4K ﹤0.01% 10004
2017
Q2 		– Sell
-2,288
Closed -$64.8K – 9854
2017
Q1 		$68K Buy
+2,288
New +$71.5K ﹤0.01% 8518
2016
Q4 		– Sell
-8,660
Closed -$572K – 10166
2016
Q3 		$572K Buy
8,660
+2,372
+38% +$148K ﹤0.01% 5829
2016
Q2 		$357K Sell
6,288
-2,825
-31% -$159K ﹤0.01% 6682
2016
Q1 		$531K Buy
9,113
+1,456
+19% +$77.3K ﹤0.01% 6296
2015
Q4 		$450K Buy
7,657
+5,272
+221% +$311K ﹤0.01% 6968
2015
Q3 		$136K Buy
2,385
+218
+10% +$17.5K ﹤0.01% 8979
2015
Q2 		$196K Sell
2,167
-3,453
-61% -$299K ﹤0.01% 9305
2015
Q1 		$541K Buy
5,620
+83
+1% +$7.67K ﹤0.01% 6951
2014
Q4 		$485K Sell
5,537
-2,268
-29% -$195K ﹤0.01% 7266
2014
Q3 		$713K Sell
7,805
-1,041
-12% -$113K ﹤0.01% 6566
2014
Q2 		$1.02M Buy
+8,846
New +$1.05M ﹤0.01% 6013
2014
Q1 		– Sell
-7,909
Closed -$1.04M – 9446
2013
Q4 		$994K Buy
7,909
+1,032
+15% +$124K ﹤0.01% 5520
2013
Q3 		$748K Buy
+6,877
New +$670K ﹤0.01% 5784

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group's TRIB Position: Q1 2026 in Review

Susquehanna International Group sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 14,249 shares — an estimated $10.5K sold.

Susquehanna International Group first reported a position in TRIB in Q3 2013 and held it in 24 quarters. The position peaked at $1.02M in Q2 2014. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Susquehanna International Group reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 14,249 Trinity Biotech shares in Q1 2026, an estimated $10.5K.
  • Susquehanna International Group first reported a position in Trinity Biotech in Q3 2013 and held it in 24 quarters.
  • Susquehanna International Group's Trinity Biotech position peaked at $1.02M in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.